Advertisement

Therapeutic Heparin May Benefit Moderately Ill COVID-19 Inpatients

0

Among those with increased D-dimer levels, no reduction seen in primary composite outcome at 28 days, but odds of death decreased

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

Biden to Nominate Former FDA Head Robert Califf to Lead Agency Again

0

If confirmed by the Senate, Califf will direct an agency responsible for more than $2.8 trillion worth of food, medical products, and tobacco

2000 to 2019 Saw Decline in Sepsis-Related Death Rates for ≥65s

0

Increase in sepsis-related death rates with age, with rate about five times higher for adults aged 85 years or older versus 65 to 74 years

CPAP, HFNO Not Tied to Greater SARS-CoV-2 Air, Surface Contamination

0

Another small study suggests cough poses higher risk for aerosol emission from the respiratory tract than CPAP, HFNO

Patient Blood Management Program May Reduce Use of Transfusions

0

Absolute risk reduction of 6 percent seen for transfusions in hospitalized adults after implementation of PBM at large academic medical center

Statin Use Not Linked to COVID-19 Mortality in Hospitalized Patients

0

Statin use associated with increased relative risk for severe disease among hospitalized patients with COVID-19

Higher Dose of Steroid Does Not Improve Outcomes in Severe COVID-19

0

Number of days alive without life support at day 28 did not differ with dexamethasone 12 mg versus 6 mg in those with severe hypoxemia

Clinically Active IBD Linked to Adverse COVID-19 Outcomes

0

Measure indicating greater activity of IBD independently linked to ICU/ventilation/death and hospitalization among patients 50 years or younger